Education and Training
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
The purpose of this study is to determine the patient preference for a biocompatible thermosensitive solution-gel versus water or saline (liquid) enema. The thermosensitive solution-gel is comprised of poloxamer, an inactive compound that is designated as GRAS (generally recognized as safe) by FDA. It could subsequently be used as a medium for drug delivery. The poloxamer (gel) is administered to study participants in order to assess preference and proximal distribution.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- other: Thermosensitive gel rectal formulation
- other: Saline enema
Eligibility
Inclusion Criteria:
- Generally healthy
- Age 18 to 70 years old
- Non-pregnant
Exclusion Criteria:
- GI complaints
- Pregnancy
- Patients with previous colonic surgery or current bowel injury or obstruction
- Allergies to contrast
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sidhartha Sinha, MD
Not Recruiting